Real world incidence and management of adverse events in patients with HR+, HER2-metastatic breast cancer receiving CDK4 and 6 inhibitors in a United States community setting
CURRENT MEDICAL RESEARCH AND OPINION（2022）
关键词
CDK4, CDK6 inhibitor, real-world utilization, metastatic breast cancer, adverse events
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要